Citigroup Inc Immuno Precise Antibodies Ltd. Call Options Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$655,7590.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$32,8440.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$17,3040.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$17,2640.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$14,8280.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $10.4M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...